Compare Medpace Holdings Inc (MEDP) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Valero Energy Corporation — how do they compare? Medpace Holdings Inc trades at $532.94 (market cap $15.08B), while Valero Energy Corporation trades at $312.19 (market cap $93.03B). The key difference: Valero Energy Corporation is far larger — about 6.2× Medpace Holdings Inc's market cap, and Valero Energy Corporation pays a 1.53% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | VLO | |
|---|---|---|
Market Cap | $15.08B | $93.03B |
Sector | Technology | Energy |
52-Week High | $620.59 | $313.31 |
52-Week Low | $308.88 | $131.77 |
Enterprise Value | $14.55B | $98.79B |
Dividend Yield | — | 1.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Valero Energy (VLO) trades at $314.81, up 1.67% on the day, with strong technical momentum and bullish moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $4.22 surpassing expectations of $3.16. Revenue declined to $122.69 billion in 2025, but net income margin held at 3.37%, supported by robust refining margins. Recent news highlights strong fuel demand and elevated crack spreads benefiting Valero's outlook.
The outlook remains positive given earnings beats, analyst buy ratings (55.55%), and refining margin tailwinds. However, declining revenue trends, high RSI levels suggesting overbought conditions, and exposure to volatile energy markets pose risks. The consensus price target of $276.22 implies potential downside from current levels, requiring careful monitoring of Q2 2026 earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
